Synthesis and activity of proteasome inhibitors

Abstract

Among its various catalytic activities, “chymotrypsin-like” activity of proteasome, a large multicatalytic proteinase complex has emerged as the focus of drug discovery efforts in cancer therapy. Herein, we report results from our investigation on a series of peptidomimetic inhibitors.